Skip to content

US study provides 'real world' evidence about which patients with hepatitis C should be prioritised for therapy

Opioid substitution therapy, especially in combination with needle exchange, reduces transmission of hepatitis C

Opioid substitution therapy, especially in combination with needle exchange, reduces transmission of hepatitis C

Studies continue to support tenofovir alafenamide combination pill as it nears US approval

Hepatitis C-related mortality continues to increase in the US

At least 25,000 people in the US may now be using PrEP

Abacavir/lamivudine could be driving liver damage in ART-treated patients with HIV/HCV co-infection

HIV attachment inhibitor BMS-663068 matches atazanavir in phase 2b study

Interferon-free treatment works well for people who inject drugs, but barriers to access remain

Affordable Care Act coverage improves chances of viral suppression for Americans with HIV